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Abstract 
Objective: Exercise leads to an increase in cardiac troponin I (cTnI) in healthy, asymptomatic athletes 
after a marathon. Previous studies revealed single factors to relate to post-race cTnI levels. Integrating 
these factors into our study, we aimed to identify independent predictors for the exercise-induced cTnI 
release. 
Design: Observational study. 
Methods: Ninety-two participants participated in a marathon at a self-selected speed. Demographic 
data, health status, physical activity levels and marathon experience were obtained. Before and 
immediately after the marathon fluid intake was recorded, body mass changes were measured to 
determine fluid balance and venous blood was drawn for analysis of high-sensitive cTnI. Exercise 
intensity was examined by recording heart rate. We included age, participation in previous marathons, 
exercise duration, exercise intensity and hydration status (relative weight change) in our model as 
potential determinants to predict post-exercise cTnI level. 
Results: cTnI increased significantly from 14±12 ng/L at baseline to 94±102 ng/L post-race, with 69% 
of the participants demonstrating cTnI levels above the clinical cut-off value (40 ng/L) for an acute 
myocardial infarction. Linear backward regression analysis identified younger age (β=-0.27) and 
longer exercise duration (β=0.23) as significant predictors of higher post-race cTnI levels (total r=0.31, 
p<0.05), but not participation in previous marathons, relative weight change and exercise intensity. 
Conclusion: We found that cTnI levels significantly increased in a large heterogeneous group of 
athletes after completing a marathon. The magnitude of this response could only be partially 
explained, with a lower age and longer exercise duration being related to higher post-race cTnI levels. 
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1. Introduction 
The presence of the cardiac troponin I (cTnI) in blood is a highly sensitive and specific biomarker for 
cardiac injury and serves as a central marker in the diagnosis of acute coronary syndromes 1-3. Many 
studies have demonstrated an increase in cTnI after prolonged endurance exercise, in the absence of 
clinical symptoms of a myocardial infarction 4-6. Relatively little is known, however, about factors that 
may be associated with, and thus potentially predict, the degree of elevation in cTnI after strenuous 
running exercise. This important information may help clinicians and laboratories with the challenging 
interpretation of elevated cTnI levels in athletes.  
 
Studies examining factors that relate to the exercise-induced increase in cTnI have predominantly 
included small and homogeneous groups of athletes. These studies demonstrated that subject 
characteristics (i.e. age and running experience) 7, exercise characteristics (i.e. exercise duration and 
intensity) 5, 8, 9, and hydration status 10 may relate to the exercise-induced increase in cTnI. These 
studies typically focused on a single factor only, thereby being unable to assess multiple parameters 
which may relate to post-race cTnI levels. As an exception to this rule, Fortescue et al. studied cardiac 
troponin responses in >400 Boston marathon runners 6. Although age and running inexperience were 
identified as factors contributing to post-exercise increases in cTnT, they did not correct for important 
confounders, such as exercise intensity 11, 12. Therefore, current studies provide only a limited insight 
into factors that could independently, or in combination, predict the magnitude of the exercise-induced 
increase in cTnI. 
 
Therefore, the aim of this study was to identify parameters that predict the elevation in cTnI after a 
marathon in a large and heterogeneous group of athletes, and to explore the interaction of the 
identified parameters using regression analysis.The novel aspect of our study is that we examined the 
potential independent predictive capacity of parameters that have previously been related to the 
exercise-induced cTnI release. We hypothesized that exercise intensity, exercise duration, age, loss of 
body mass and running experience independently predict post-race cTnI levels. 
2. Methods 
A total of 92 moderately to highly trained runners (26 to 71 years of age) of the Eindhoven Marathon 
2010 (The Netherlands) were recruited to the study. An advertisement was placed on the Eindhoven 
Marathons website to recruit participants. Before participation all participants provided written 
informed consent. The medical ethical committee of the Radboud University Nijmegen Medical 
Centre approved the study which was conducted in line with the Declaration of Helsinki. 
 
All participants completed an online questionnaire about subject characteristics, including daily 
physical activity, marathon experience (e.g. previous completed marathons, personal record) and 
health (e.g. medical history and medication use). On the day of the marathon, participants underwent a 
series of measurements in our laboratory near the start/finish area. After demographic data were 
obtained a venous blood sample was taken. Heart rate was monitored continuously during the race 
using a chest band. Immediately after the marathon (<5 minutes), all measurements were repeated in 
the same order. Additionally, participants reported their fluid intake, use of analgesics, physical 
complaints and rate of perceived exertion. 
 
Ten ml of blood was drawn from an antecubital vein before and immediately after the race. Whole 
venous blood was collected in serum-gel vacutainer tubes and allowed to clot for ~45 minutes. After 
centrifugation, serum was aliquoted, frozen, and stored at -80°C for later analysis. Analysis was 
performed on a single day using the same calibration and set-up to minimize variation. cTnI was 
analysed using a high-sensitive cTnI assay (Centaur TnI-Ultra, Siemens Healthcare Diagnostics, 
Breda, the Netherlands). The assay imprecision was 5.3% at 80 ng/L and 3.0% at 27200 ng/L, with a 
detection limit of 6 ng/L. A cTnI value of 40 ng/L was used as the clinical cut-off value for an acute 
myocardial infarction 13. 
Heart rate during the marathon was measured in 70 athletes by using a 2-channel ECG chest 
band system (Polar Electro Oy, Kempele, Finland). Mean heart rate (HRmean) was determined as the 
average heart rate between the start and finish of the marathon. Maximal predicted heart rate 
(HRmax=208–0.7*age) and exercise intensity (Exercise intensity=100*HRmean/HRmax) were 
calculated subsequently 14. 
Finish time (exercise duration) was obtained using the ChampionChip time registration 
(ChampionChip®, MYLAPS, The Netherlands), out of which mean running speed was calculated 
(Speed=42.195/exercise duration). 
After the marathon, participants completed a questionnaire indicating analgesic use and 
physical complaints. A visual analogue scale (0 - no effort; 10 - maximal effort) was used to measure 
rate of perceived exertion. 
Participants were allowed to drink ad libitum during the race, whereas they registered the time 
and amount (standard sized cups, bottles, etc.) of their individual fluid intake after the finish. 
Baseline and post-exercise body mass were assessed (Seca 888 Scale, Seca, Hamburg, 
Germany) to detect changes in hydration status. The relative change in body mass (in %) between the 
measurements was calculated, while dehydration was defined as a body mass loss of 2% or more 15, 16. 
An additional 2 ml of blood was drawn at baseline and directly after finishing to determine 
plasma levels of sodium, hematocrit and haemoglobin (RapidLab® 1265, Siemens Healthcare 
Diagnostics Inc., Tarrytown, New York, U.S.A.). Hyponatraemia was defined as a sodium 
concentration ≤135mmol/L, whereas hypernatraemia was defined as a sodium concentration ≥145 
mmol/L 17, 18.  
 
All data were reported as mean±SD [range] unless stated otherwise and statistical significance was 
assumed at a p-value<0.05. Statistical analyses were performed using the Statistical Package for the 
Social Sciences (IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.). The 
normality of the data distribution was examined by the Kolmogorov-Smirnov test. When data 
demonstrated a non-Gaussian distribution, natural logarithmic transformation was applied. Differences 
between pre- and post-race levels for continuously distributed data were tested for significance with a 
Paired Student’s t-test. A backward stepwise linear regression analysis was used to identify factors 
that significantly relate to post-exercise cTnI-levels. Based on our hypothesis, we have included age, 
participation in previous marathons, exercise duration, exercise intensity and hydration status  in our 
model as potential determinants to predict post-exercise cTnI level. All predictors with a p-
value<0.1 were retained in our final regression model. 
 
3. Results 
During the race mean wet bulb globe temperature (WBGT) was 18.8 °C, with a relative humidity of 
52%. Of the 92 participants who started the race, 9 participants did not finish the race, because of 
exhaustion (n=2), acute knee problems (n=1), heat (n=1), dyspnoea (n=1), hip problems (n=1), 
headache (n=1) or another sport-related injury (n=2) and were therefore not included in the analysis. 
One participant was excluded afterwards because of missing multiple data-points. Therefore, 82 
participants were included in the data analysis (17 females and 65 males). Demographic characteristics 
and the medical history of participants are presented in Table 1. On average, participants exercised 
8.4±3.4 [3-18] hours per week and had completed 8±16 [0-102] marathons in the past, with a mean 
personal record (marathon PR) of 210±22 [166-256] minutes.  
 
Post-race blood withdrawal failed in 2 participants. Ln-transformation was applied to the cTnI data set, 
as a non-Gaussian distribution was found. A significant exercise-induced increase in cTnI was 
observed, from 14±12 [0-49] ng/L at baseline to 94±102 [3–530] ng/L immediately after the finish 
(Figure 1, p<0.001). In total, 96 % of the participants demonstrated an increase in cTnI levels, with 55 
participants (69%)  exceeding the clinical cut-off value of 40 ng/L after completing the marathon 
(Table 2).  
 
The average finish time of the marathon was 227±28 [169-307] minutes with a mean speed of 
11.3±1.4 [8.2-15.0] km/hr. Participants demonstrated an mean heart rate of 161±9 [136-178] beats per 
minute, which is comparable to an exercise intensity of 91±5 [76-100] % of the maximal predicted 
heart rate. Participants scored the post-race rate of perceived exertion with 7±2 [1-10] (Table 2). 
 
Between 12.00 PM and the start of the marathon (i.e. 11.00 AM), participants consumed 1311±848 
[125-5330] ml fluid. During the race a total of 2406±1597 [300-6750] ml was consumed (Table 2), 
which is equal to 644±430 [70-1852] ml/h. As a measure of hydration status, changes in body mass 
were determined. Our population demonstrated a significant decrease in body mass after finishing the 
marathon (p<0.001). The average change in body mass was -1.8±0.9 kg [-4.3–+0.5 kg], with 52 
participants (63%) meeting the criteria for being dehydrated (≥2% body mass loss). This was 
accompanied by a significant increase in plasma sodium concentration (p<0.005), whilst 18 athletes 
(22%) finished with a sodium level above 145 mmol/l (Table 2). No significant changes in 
haemoglobin concentration (p=0.81) and hematocrit levels (p=0.88) were observed between baseline 
and finish.  
 
Backward linear regression analysis was performed in a dataset of 67 athletes in whom all parameters 
were successfully measured. We identified lower age (standardized β=-0.265, p<0.05) and longer 
exercise duration (standardized β=0.230, p=0.066) as independent predictors of higher post-race cTnI 
levels. Participation in previous marathons, exercise intensity and hydration status (relative body mass 
change) did not reach statistical significance and were therefore excluded by the regression analysis as 
contributors of post-race cTnI levels. Our prediction model had an overall r=0.305 (p<0.05), with an 
explained variance of 9.3%.  
 
4. Discussion 
This study confirmed the presence of exercise-induced release of cTnI in asymptomatic, healthy 
athletes competing in a marathon. In accordance with previous studies, cTnI levels increased 
significantly in our post-race blood sample, with 69% of the participants showing cTnI levels above 
the clinical cut-off point used for the diagnosis of an acute myocardial infarction 6, 7, 19. The novel 
aspect of our study is that we examined the potential independent predictive capacity of parameters 
that have previously been related to the exercise-induced cTnI release. We determined that only 
younger age and longer exercise duration were significantly related to higher post-race cTnI levels. 
Despite including a range of personal and exercise related factors that have previously been linked to 
post-exercise cTnI levels, we could only predict a small portion of the total variance in post-race cTnI 
levels. 
 
Age and post-race cTnI levels demonstrated an inverse relationship. This observation is in line with 
other studies 6, 7, 11, but in contrast with a meta-analysis 20. A potential relation may be explained by the 
exercise mode. Whilst the meta-analysis included data from running, cycling and triathlon studies 20, 
we focussed on marathon athletes only and included a heterogeneous group of participants in respect 
to age (n=82, 26-71 years). Indeed, another review that included marathon studies only, revealed a 
trend for a lower post-race troponin in older athletes 21. A potential explanation for the age-dependent 
cTnI release might relate to the higher exercise intensity, and therefore the higher work of the heart 
muscle, in younger athletes 12. Previous studies in small and homogenous cohorts reported that a 
higher exercise intensity is related to a larger exercise-induced cTnI increase 20, 22. The variation in 
exercise intensity in our participants was, however, too small to support these findings (91 ± 5% of 
HRmax). However, additional analysis revealed a significant correlation between age and absolute 
heart rate (r=-0.41, p<0.001). Accordingly, the higher post-race cTnI levels in the younger athletes 
may be related to their higher absolute heart rate, which apparently results in a larger cardiac stress.  
 
We also observed a positive relationship between exercise duration and post-race cTnI levels. 
Although this finding is in line with some of the recent field and laboratory studies 8, 9, others have 
reported an opposite relationship between post-race cTnI levels and exercise duration 20, 23. These latter 
studies suggest that longer exercise duration is usually related to lower exercise intensity, and 
consequently to a lower increase in exercise induced cTnI levels 20, 24. In our study, participants did not 
demonstrate a relation between finish time and exercise intensity (r=0.11, p=0.36). Given the 
homogeneous exercise intensity in our population, participants with longer exercise duration were 
exposed to a higher cardiac stress. The release of exercise-induced cTnI levels in participants with 
longer exercise duration may therefore relate to the higher cardiac work. However, it must be 
emphasised that future studies should further examine whether troponin-release after exercise relates 
to absolute cardiac work, independent of exercise type.  
 
Previous studies have identified various factors that may contribute to exercise-induced release of 
cTnI. Nonetheless, when including these factors in our statistical model, only exercise intensity and 
age were independently related to the exercise induced cTnI levels during this field-based study. In 
contrast with a previous study 10, we found no evidence for a relation between hydration status and 
post-race cTnI levels. Also, running experience (previous marathon participation) was not related to 
the magnitude of post-race cTnI release in our data set 6, 7, 12. Whilst previous studies typically focused 
on a single factor, our statistical model corrected for the potential underlying interaction between 
predictors for post-race cTnI levels. For example, higher age is strongly related to running experience 
and exercise intensity. As a result, our study indicates that neither marathon (in)experience nor 
hydration status are related to the exercise-induced troponin elevations.  
 
The aetiology of exercise-induced elevations in cardiac troponins remains a topic of debate. Six 
pathobiological mechanisms that explain the elevated cTnI levels have been proposed. First, elevated 
troponin levels could be related to an increased membrane permeability during exercise 25, 26, allowing 
unbound cardiac troponins in the cystolic pool (<10%) to enter the circulation 27. Second, cellular 
release of proteolytic troponin degradation products may contribute to elevated cTnI levels 28, while 
membrane integrity is maintained 29. Third, formation and active release of membranous blebs during 
temporary ischemia of cardiac cells may cause elevation of troponin concentrations 30. Fourth, exercise 
may stimulate myocyte turnover, which subsequently could cause an elevation in cTnI levels 31. 
Finally, myocyte necrosis and/or an elevated rate of apoptosis may contribute to the exercise-induced 
increase of cTnI. Whilst our study provides novel insight into factors that relate to the exercise-
induced increase in cTnI, studies are warranted to directly examine the underlying mechanisms of 
elevated post-race troponin levels. Such information will reveal important information regarding the 
physiological versus pathological nature of troponin release in athletes after exercise.  
 
We found that 96% of our marathon athletes demonstrated an increase in cTnI, while 69% of our 
population exceeded the clinical cut-off value. Since cTnI is recommended as a sensitive and specific 
marker for cardiac damage in the diagnosis of acute myocardial infarction 3, 32, caution should be taken 
when interpreting post-race cTnI levels. As our participants did not report any symptoms, it is likely 
that the elevated cTnI levels represent a physiological rather than a pathological response 33. Clinicians 
should therefore take caution when examining troponin levels without clinical signs indicative of 
myocardial ischemia 34. Our study provides some additional clinical insight as we found that lower age 
and longer exercise duration, albeit weakly, independent predict post-race cTnI levels. Such 
information is relevant for clinicians as it could improve medical decision making.  
 
The predictive value of our statistical model is low (r2=9.3%) and indicates that a large portion of the 
post-race cTnI levels cannot be explained. Therefore, one may suggest that responses are apparently 
irrespective of subject and exercise characteristics, and post-race cTnI levels may reflect a 
physiological response during exercise. Another limitation may be our single post-exercise assessment 
of cTnI, as previous observations reported a time-dependent change in cTnI after a marathon 35. While 
we focused on post-race cTnI levels only, the relative contribution of predictors might differ during 
the time-course of exercise-induced cTnI-release. 
 
5. Conclusion 
In conclusion, we found that cTnI levels increased in a large heterogeneous group of athletes after 
completing a marathon. Including previously identified factors that relate to the exercise-induced 
release of cTnI into a statistical model, we found that the presence of this response was inversely 
correlated to the age of participants, whilst longer exercise duration also resulted in higher exercise 
induced troponin levels. Other factors that have previously been demonstrated to relate to post-
exercise cTnI (i.e. exercise intensity, fluid status and marathon experience), were not related to post-
marathon cTnI levels when correcting for potential interactions.  Given the low explained variance of 
9.3%, exercise-induced cTnI levels seem to be largely irrespective of individual and exercise 
characteristics. 
 
Practical implications 
• Cardiac troponin levels elevate in all athletes after running a marathon 
• 69% of marathon athletes exceed the clinical threshold of cardiac troponin levels directly post-
race.  
• Age and exercise duration can partially predict the post-race cardiac troponin levels 
• Exercise-induced cardiac troponin elevations are more likely to reflect a physiological rather 
than a pathological response. 
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Figure legends 
Figure 1: Frequency distribution of cardiac troponin I levels (cTnI) in 82 athletes directly after the 
finish of the Eindhoven marathon. The average cTnI level increased from 14±12 ng/L at baseline to 
94±102 ng/L directly post-exercise. In addition 55 (69%) of our participants exceeded the clinical cut-
off value for an acute myocardial infarction (represented by the dashed line). 
Figure 1. 
 
Table 1. Subject characteristics and details about the health status of 82 athletes that 
finished the Eindhoven marathon. 
  N Mean±SD Range 
Demographic characteristics    
 Age (yr) 82 45±8 26-71 
 Height (m) 82 1.79±0.10 1.58-2.00 
 Body-mass index (kg/m2) 82 22.9±2.2 16.2-29.0 
 Previous marathons 82 8.2±15.7 0-103 
 Completed marathons 82 8±16 0-102 
 Sport (hrs/week) 82 8.4±3.4 3-18 
 Marathon PR (min) 58 210±22 166-256 
    
Medical history N Percentage   
 Hypercholesterolemia 10 12%  
       on medication 3 4%  
 Asthma 8 10%  
       on medication 1 1%  
 Hypertension 4 5%  
       on medication 3 4%  
 Anaemia 4 5%  
 Rheumatic complaints 3 4%  
       on medication 1 1%  
 Cancer (history) 2 2%  
 
Table 2. Baseline and finish values of cardiac troponin, exercise characteristics and 
hydration status. 
 
Baseline Finish P-value 
Cardiac troponin 
 
 
 cTnI (ng/L) 
 
14±12 
[0-49] 
94±102 
[3–530] 
<0.001 
 
cTnI > 40 ng/L (n (%)) 5 (6%) 55 (69%) <0.001 
Exercise characteristics 
 
 
 Heart rate (bpm) 
  
161±9 
[136-178]  
Exercise intensity (% HRmax) 
  
91±5 
[76-100]  
Exercise duration (min) 
  
227±28 
[169-307]  
Speed (km/hr) 
  
11.3±1.4 
[8.2-15.0]  
Rate of perceived exertion 
  
7±2 
[1-10]  
Hydration status 
 
 
 Fluid intake during race (L) 
 
 
2.4±1.6 
[0.3-6.8] 
     % water 
 
59% 
     % sports drink 
 
39% 
     % other 
 
2% 
 Body mass (kg) 
 
73.3±10.5 
[52.5–93.9] 
71.5±10.1 
[51.6–92.2] 
<0.001 
 
Absolute body mass changes (kg) 
 
 
-1.8±0.9 
[-4.3–+0.5] 
 
Relative body mass changes (%) 
 
 
-2.4±1.2 
[-5.6–0.6] 
 Dehydration (n (%)) 
 
52 (63%) 
 Plasma sodium concentration (mmol/L) 
 
141.3±1.9 
[137.2-145.8] 
142.4±3.0 
[132.6-148.5] 
0.003 
 
Hypernatreamia, ≥ 145 mmol/L (n (%)) 4 (5%) 14 (17%) 0.012 
Hyponatreamia, ≤ 135 mmol/L (n (%)) 0 (0%) 3 (4%) 0.075 
Hemoglobin concentration (mmol/L) 
 
9.5±0.6 
[8.1-10.8] 
9.5±0.7 
[7.5-11.8] 
0.811 
 
Hematocrit levels (%) 
 
45±3 
[39-51] 
45±3 
[36-56] 
0.883 
 
P-value refers to a Paired Student’s t-test between baseline and finish values 
 
 
 
